Literature DB >> 17989107

Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis.

M C Wapenaar1, A J Monsuur, A A van Bodegraven, R K Weersma, M R Bevova, R K Linskens, P Howdle, G Holmes, C J Mulder, G Dijkstra, D A van Heel, C Wijmenga.   

Abstract

BACKGROUND: Coeliac disease (gluten-sensitive enteropathy; GSE) and inflammatory bowel disease (IBD) are common gastrointestinal disorders. Both display enhanced intestinal permeability, initiated by gluten exposure (GSE) or bacterial interactions (IBD). Previous studies showed the association of both diseases with variants in MYO9B, presumably involved in epithelial permeability. AIM: It was hypothesised that genetic variants in tight junction genes might affect epithelial barrier function, thus contributing to a shared pathogenesis of GSE and IBD.
METHODS: This hypothesis was tested with a comprehensive genetic association analysis of 41 genes from the tight junction pathway, represented by 197 tag single nucleotide polymorphism (SNP) markers.
RESULTS: Two genes, PARD3 (two SNPs) and MAGI2 (two SNPs), showed weak association with GSE in a Dutch cohort. Replication in a British GSE cohort yielded significance for one SNP in PARD3 and suggestive associations for two additional SNPs, one each in PARD3 and MAGI2. Joint analysis of the British and Dutch data further substantiated the association for both PARD3 (rs10763976, p = 6.4 x 10(-5); OR 1.23, 95% CI 1.11 to 1.37) and MAGI2 (rs6962966, p = 7.6 x 10(-4); OR 1.19, 95% CI 1.08 to 1.32). Association was also observed in Dutch ulcerative colitis patients with MAGI2 (rs6962966, p = 0.0036; OR 1.26, 95% CI 1.08 to 1.47), and suggestive association with PARD3 (rs4379776, p = 0.068).
CONCLUSIONS: These results suggest that coeliac disease and ulcerative colitis may share a common aetiology through tight junction-mediated barrier defects, although the observations need further replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989107     DOI: 10.1136/gut.2007.133132

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  61 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Zonulin, regulation of tight junctions, and autoimmune diseases.

Authors:  Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 3.  Detecting shared pathogenesis from the shared genetics of immune-related diseases.

Authors:  Alexandra Zhernakova; Cleo C van Diemen; Cisca Wijmenga
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

4.  Shared susceptibility for celiac disease and inflammatory bowel disease?

Authors:  Ying Gao; Martha S Linet; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Lynn R Goldin; Ola Landgren
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

5.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 6.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

7.  Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.

Authors:  Craig Sturgeon; Jinggang Lan; Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2017-04-19       Impact factor: 5.691

Review 8.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 9.  Intestinal microbiota and probiotics in celiac disease.

Authors:  Luís Fernando de Sousa Moraes; Lukasz Marcin Grzeskowiak; Tatiana Fiche de Sales Teixeira; Maria do Carmo Gouveia Peluzio
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 10.  Biological pathways involved in the development of inflammatory bowel disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Saska Lipovsek
Journal:  Wien Klin Wochenschr       Date:  2014-09-26       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.